Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The TouchPoint Solution is a health technology company that develops wearable devices designed to alleviate stress and improve focus. The company's flagship product, TouchPoints, utilizes proprietary Bi-Lateral Alternating Stimulation Tactile (BLAST) technology to shift the user from a 'fight or flight' sympathetic nervous system response to a 'rest and digest' parasympathetic state. These non-invasive wearables are used to manage symptoms of anxiety, ADHD, and PTSD, as well as to improve sleep quality. Founded by entrepreneur Vicki Mayo and neuropsychologist Dr. Amy Serin, the company aims to provide accessible, drug-free solutions for mental wellness. The technology is backed by clinical research and is marketed directly to consumers and healthcare professionals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The TouchPoint Solution.